BBI Grants

Study of Electronic Health Records Demonstrates Value of Data in Referring Patients for Genetic Testing

June 11, 2021 | by BBI Communications

Members of the Brotman Baty Institute for Precision Medicine (BBI) are using electronic health records to identify women with a risk of having a genetic predisposition to breast cancer.

Read More

BBI ‘Catalytic Collaboration’ Grant Leads to ‘Extraordinary’ Progress in Research for Directing Treatment of Multiple Myeloma Patients

June 01, 2021 | by BBI COMMUNICATIONS

“Although recent advances have led to a surge in the number of therapies available to treat Multiple Myeloma, it remains a challenge to identify which treatment a patient is most likely to respond to.” Dr. David Coffey, Fred Hutchinson Cancer Research Center

Read More

BBI ‘Catalytic Collaboration Grant’ funded in 2019 Leads to Promising Genetic Diagnoses of Rare Diseases

May 03, 2021 | by BBI COMMUNICATIONS

“There is a need for better tools to identify a precise genetic diagnosis in individuals when conventional testing approaches have been exhausted.” – Dr. Evan Eichler, Professor of Genome Sciences, UW School of Medicine

Read More

BBI ‘Catalytic Collaboration Grant’: Bringing Precision Medicine to Pancreatic Cancer

May 13, 2021 | by BBI Communications

NOTE: The Brotman Baty Institute for Precision Medicine (BBI), in fulfilling its goal to create a community of investigators across its three founding institutions, awards grants each year to advance basic science and translational research related to precision medicine.

Read More